Variant report
Variant | nsv522325 |
---|---|
Chromosome Location | chr6:29544825-29550618 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:19)
- CpG islands (count:551)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:19 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr6:29548640-29548938 | HepG2 | liver: | n/a | chr6:29548797-29548808 |
2 | CTCF | chr6:29548660-29548810 | WERI-Rb-1 | eye: | n/a | n/a |
3 | E2F4 | chr6:29547709-29547868 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | JUN | chr6:29545419-29545680 | HepG2 | liver: | n/a | chr6:29545505-29545518 |
5 | JUND | chr6:29545349-29545673 | HepG2 | liver: | n/a | n/a |
6 | MAFF | chr6:29548720-29548811 | HepG2 | liver: | n/a | n/a |
7 | MYC | chr6:29545317-29545419 | NB4 | blood: | n/a | n/a |
8 | POLR2A | chr6:29548245-29549410 | H1-neurons | neurons: | n/a | n/a |
9 | POLR2A | chr6:29548814-29548985 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | POLR2A | chr6:29547256-29547764 | H1-neurons | neurons: | n/a | n/a |
11 | POLR2A | chr6:29544604-29544913 | H1-neurons | neurons: | n/a | n/a |
12 | POLR2A | chr6:29545207-29545595 | H1-neurons | neurons: | n/a | n/a |
13 | POLR2A | chr6:29547543-29547658 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr6:29549980-29550721 | H1-neurons | neurons: | n/a | n/a |
15 | POLR2A | chr6:29548453-29549307 | H1-neurons | neurons: | n/a | n/a |
16 | POLR2A | chr6:29549946-29550744 | H1-neurons | neurons: | n/a | n/a |
17 | RAD21 | chr6:29549549-29549558 | A549 | lung: | n/a | n/a |
18 | STAT3 | chr6:29549412-29549612 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | USF1 | chr6:29548947-29549221 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29550425-29550475 | AG04449 | skin: | fetal |
2 | chr6:29550425-29550475 | SKMC | muscle: | n/a |
3 | chr6:29550425-29550475 | AG04449 | skin: | fetal |
4 | chr6:29550425-29550475 | SKMC | muscle: | n/a |
5 | chr6:29549147-29549197 | AG10803 | skin: | n/a |
6 | chr6:29549352-29549402 | GM12878 | blood: | n/a |
7 | chr6:29549352-29549402 | HepG2 | liver: | n/a |
8 | chr6:29548535-29548585 | Hepatocyte | liver: | n/a |
9 | chr6:29549147-29549197 | SK-N-MC | brain: | n/a |
10 | chr6:29550134-29550184 | AoSMC | blood vessel: | n/a |
11 | chr6:29549759-29549809 | ECC-1 | luminal epithelium: | n/a |
12 | chr6:29549147-29549197 | NH-A | brain: | n/a |
13 | chr6:29549180-29549230 | PANC-1 | pancreas: | n/a |
14 | chr6:29549147-29549197 | Caco-2 | colon: | n/a |
15 | chr6:29550134-29550184 | GM12891 | blood: | n/a |
16 | chr6:29548535-29548585 | GM06990 | blood: | n/a |
17 | chr6:29550134-29550184 | HCM | heart: | n/a |
18 | chr6:29549724-29549774 | HPAEpiC | pulmonary alveolar: | n/a |
19 | chr6:29548691-29548741 | MCF-7 | breast: | n/a |
20 | chr6:29549352-29549402 | Hepatocyte | liver: | n/a |
21 | chr6:29548691-29548741 | HCF | heart: | n/a |
22 | chr6:29548535-29548585 | GM12891 | blood: | n/a |
23 | chr6:29548535-29548585 | AG10803 | skin: | n/a |
24 | chr6:29549180-29549230 | SKMC | muscle: | n/a |
25 | chr6:29550134-29550184 | HCT-116 | colon: | n/a |
26 | chr6:29550425-29550475 | RPTEC | kidney: | n/a |
27 | chr6:29550425-29550475 | HRE | kidney: | n/a |
28 | chr6:29549180-29549230 | HCF | heart: | n/a |
29 | chr6:29548691-29548741 | NHDF-neo | bronchial: | n/a |
30 | chr6:29550134-29550184 | NHBE | bronchial: | n/a |
31 | chr6:29548691-29548741 | RPTEC | kidney: | n/a |
32 | chr6:29549759-29549809 | Hela-S3 | cervix: | n/a |
33 | chr6:29548535-29548585 | HAEpiC | amniotic membrane: | n/a |
34 | chr6:29549724-29549774 | HEK293 | kidney: | embryo |
35 | chr6:29550425-29550475 | GM12891 | blood: | n/a |
36 | chr6:29549724-29549774 | HUVEC | blood vessel: | n/a |
37 | chr6:29549180-29549230 | PFSK-1 | brain: | n/a |
38 | chr6:29549180-29549230 | MCF10A-Er-Src | breast: | n/a |
39 | chr6:29549180-29549230 | SK-N-SH_RA | brain: | n/a |
40 | chr6:29548535-29548585 | PFSK-1 | brain: | n/a |
41 | chr6:29550425-29550475 | HCPEpiC | choroid plexus: | n/a |
42 | chr6:29550425-29550475 | BE2_C | brain: | n/a |
43 | chr6:29550134-29550184 | MCF10A-Er-Src | breast: | n/a |
44 | chr6:29548691-29548741 | HMEC | breast: | n/a |
45 | chr6:29550425-29550475 | Hepatocyte | liver: | n/a |
46 | chr6:29549759-29549809 | GM19239 | blood: | n/a |
47 | chr6:29549724-29549774 | HMEC | breast: | n/a |
48 | chr6:29548691-29548741 | GM12878 | blood: | n/a |
49 | chr6:29548691-29548741 | HPAEpiC | pulmonary alveolar: | n/a |
50 | chr6:29548535-29548585 | AG09309 | skin: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29542932..29546952-chr6:29547558..29549945,4 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OR2H2-3 | chr6:29545236-29545525 | NONHSAT108529 |
No data |
No data |
Variant related genes | Relation type |
---|---|
SNORD32B | TF binding region |
TMEM183AP1 | TF binding region |
RPL13AP | TF binding region |
SNORD32B | CpG island |
TMEM183AP1 | CpG island |
RPL13AP | CpG island |
ENSG00000227609 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3117073 | chr6:29544825-29544826 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs183354702 | chr6:29544843-29544844 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs565141258 | chr6:29544855-29544856 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs371310332 | chr6:29544890-29544891 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs144891670 | chr6:29544919-29544920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544736706 | chr6:29544931-29544932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187606699 | chr6:29544965-29544966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546515844 | chr6:29544981-29544982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532529427 | chr6:29545020-29545021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547974445 | chr6:29545032-29545033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140804574 | chr6:29545056-29545057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs375527364 | chr6:29545117-29545118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552121313 | chr6:29545130-29545131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540204954 | chr6:29545135-29545136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561667993 | chr6:29545173-29545174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568526861 | chr6:29545190-29545191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs362522 | chr6:29545208-29545209 | Weak transcription Enhancers | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs547860687 | chr6:29545223-29545224 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs567862387 | chr6:29545231-29545232 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs3025649 | chr6:29545232-29545233 | Weak transcription Enhancers | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs562677586 | chr6:29545242-29545243 | Weak transcription Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs374357401 | chr6:29545283-29545284 | Weak transcription Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs538987764 | chr6:29545306-29545307 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs558880164 | chr6:29545352-29545353 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs575696142 | chr6:29545354-29545355 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs551718492 | chr6:29545360-29545361 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs542413038 | chr6:29545369-29545370 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs201922225 | chr6:29545378-29545379 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs574993624 | chr6:29545381-29545382 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs540373443 | chr6:29545385-29545386 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs115339611 | chr6:29545418-29545419 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs532400197 | chr6:29545440-29545441 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs144637271 | chr6:29545473-29545474 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs34927823 | chr6:29545494-29545495 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs190572902 | chr6:29545516-29545517 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs547822665 | chr6:29545517-29545518 | Weak transcription Enhancers | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs373948102 | chr6:29545530-29545531 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs79392933 | chr6:29545602-29545603 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs546961226 | chr6:29545639-29545640 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs547145994 | chr6:29545650-29545651 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs376839887 | chr6:29545690-29545691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1233397 | chr6:29545715-29545716 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs146700218 | chr6:29545721-29545722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556994944 | chr6:29545826-29545827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575449135 | chr6:29545932-29545933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576046024 | chr6:29546000-29546001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs28986296 | chr6:29546004-29546005 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs182728988 | chr6:29546007-29546008 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188153128 | chr6:29546029-29546030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540385194 | chr6:29546090-29546091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 17363583 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29541200-29553200 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr6:29542200-29545200 | Weak transcription | Spleen | Spleen |
3 | chr6:29545200-29545400 | Enhancers | Spleen | Spleen |
4 | chr6:29545400-29545600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr6:29545400-29549800 | Weak transcription | Spleen | Spleen |
6 | chr6:29546000-29546200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr6:29546000-29546600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr6:29546000-29546600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr6:29546200-29546400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr6:29546200-29569400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr6:29549000-29549200 | Enhancers | HMEC | breast |